Unfolding insights: How nanoDSF is reshaping biotherapeutics development at Johnson & Johnson Innovative Medicine

May 22, 2025 Léa Valla

At a recent webinar hosted by NanoTemper, Dr. Marius Müller of Johnson & Johnson Innovative Medicine shared valuable behind-the-scenes insights into the use of nanoDSF™ technology (supported by the newly launched Prometheus™  Panta C instrument). His team not only benefits from nanoDSF for precise identity (ID) testing of biologics but across multiple stages of biotherapeutic development.

The Q&A session revealed powerful, practical applications in a regulated pharma environment.

Here are five questions asked by our audience and what they reveal about the technology’s capabilities:


1. Beyond ID-testing: Where else is nanoDSF making an impact?

Dr. Müller highlighted how his use of the technology has evolved over the last seven years, to become a “workhorse” for process characterization and stress testing. In particular:

  • Thermal stability of biologics is tracked during manufacturing to assess impacts of stress.
  • Low-concentration products benefit from nanoDSF detection of intrinsic fluorescence, outperforming traditional absorbance techniques.

nanoDSF, supported by the Prometheus Panta C stands out for its reliability in regulated environments, providing robust data without compromising standards.


2. Batch vs. continuous manufacturing: How does nanoDSF hold up?

In the context of continuous manufacturing, a key concern is whether ID testing with nanoDSF keeps up with faster processes. Dr. Müller shared his experience:

  • The speed and accuracy of nanoDSF makes it ideal for makes it ideal for either batch or continuous manufacturing.
  • Results can be delivered within hours, allowing for fill-at-risk strategies—minimizing downtime while maintaining quality.

This makes both the nanoDSF technology and the Prometheus Panta C instruments valuable assets for modern manufacturing paradigms, including campaign-based or fully continuous models.


3. How precise is nanoDSF? Can it distinguish similar Biologics?
When asked whether nanoDSF could differentiate between structurally similar products, such as closely related IgG1 antibodies, Dr. Müller confirmed that:

  • Even subtle structural or formulation differences can yield distinct thermal unfolding profiles.
  • The technology accounts for concentration effects, buffer environments, and matrix composition, making it sensitive to a range of variables.

This makes nanoDSF ideal for complex portfolios, including bispecifics and tri-specifics, where high discrimination is essential.


4. What happens under stress or suboptimal storage conditions?

What is the impact of stress conditions on identification accuracy? Dr. Müller noted that while this can alter the thermal profile and potentially prevent correct identification, that’s precisely the point:

  • If a sample drifts outside of acceptable quality limits, it shouldn’t pass ID testing.
    nanoDSF can serve as an early warning system, flagging degraded or compromised samples before they move further along the pipeline.
  • This makes nanoDSF not just a tool for identity verification, but also a quality safeguard.

 
5. When it comes to formulation fingerprints do you need a reference standard? Or can nanoDSF stand alone?
Another major advantage of nanoDSF is its ability to operate without constant reference to physical standards:

  • At J&J, the team developed data-driven models to create a reference space for product fingerprints.
  • This enables repeatable, scalable ID testing without needing a specific reference sample each time.

Notably, nanoDSF could even distinguish between different generations of the same product following formulation changes—something many conventional techniques like dot blot assays cannot do.


 
Key Learnings:

From robust ID testing to nuanced formulation discrimination and continuous manufacturing integration, nanoDSF technology supported by Prometheus Panta C is enabling a new level of precision and efficiency in biotherapeutic development at Johnson & Johnson.

As Dr. Müller put it, “Even we, in this regulated environment, can get so much out of it.”

The technology is more than just compliant—it’s transformative.
 
Interested in exploring Prometheus Panta C for your own lab? Visit our dedicated page. 

Previous Article
Mastering Protein Labeling: Your Guide to Accurate, Reliable Results
Mastering Protein Labeling: Your Guide to Accurate, Reliable Results

Protein labeling is the gateway to uncovering intricate details about protein structures, functions, and in...

Up next
NanoTemper Announces Prometheus Panta C: Powering Biopharma Breakthroughs from Preclinical to Commercial Manufacturing
NanoTemper Announces Prometheus Panta C: Powering Biopharma Breakthroughs from Preclinical to Commercial Manufacturing

NanoTemper Technologies announces the launch of Prometheus Panta C, a solution designed to meet the evolvin...